Consistent with this, the high expression of both ELVOL1 and ELOVL3 would reduce the overall survival (OS) (Figures 3C, E) and disease-free survival (DFS) (Figures 3D, F) of patients with HCC. Here, ELOVL3 is linked to hepatocellular carcinoma.